Analysis of the Incidence and Severity of Cellulitis During the <scp>COVID</scp> ‐19 Pandemic in Japan

During the COVID-19 pandemic, a decline in various infectious disease cases was observed. However, changes in dermatological infectious diseases, particularly cellulitis, and the potential impact of delayed consultations on severe cases have not been fully explored. To investigate changes in the number of cellulitis patients and severe cases during the COVID-19 pandemic. We employed a difference-in-differences (DID) design using a de-identified claims database from 242 acute-care hospitals across Japan to compare the pre-pandemic period (January 1, 2015, to December 31, 2019) with the pandemic period (January 1, 2020, to December 31, 2020). The national state of emergency, declared by the Japanese government in April 2020 in response to COVID-19, was treated as an exogenous shock. The study analyzed outpatient, inpatient, and total cases, sepsis and bacteremia complications, ambulance transport rates, length of hospital stay, and inpatient comorbidities. A total of 28 673 cellulitis cases were analyzed (24 256 from 2015 to 2019; 4417 in 2020). Severity indicators included hospitalization (8.2%), sepsis (4.1%), bacteremia (1.7%), and ambulance transport (17.0%). In the DID analysis, a significant decrease was observed in total cellulitis cases (incidence rate ratio [IRR]: 0.91; 95% confidence interval [CI]: 0.85-0.97), outpatient cases (IRR: 0.92; 95% CI: 0.86-0.98), and inpatient cases (IRR: 0.81; 95% CI: 0.66-0.99). No significant differences were found in sepsis (IRR: 0.53; 95% CI: 0.26-1.10), bacteremia (IRR: 0.73; 95% CI: 0.19-2.86), ambulance transport (IRR: 0.81; 95% CI: 0.50-1.29), or length of hospital stay (IRR: 0.83; 95% CI: 0.66-1.03). During the pandemic, the number of cellulitis cases treated in Japanese acute-care hospitals decreased without a significant rise in severe cases, suggesting the possibility that avoidance of medical consultations may not have worsened outcomes. Pandemic-related behavioral changes may have contributed to the reduced incidence.

Authors

Institutions

Publication Details

Journal
The Journal of Dermatology
Published
2025-07-14
DOI
https://doi.org/10.1111/1346-8138.17853
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan

Atsushi Miyawaki, Kazuhiro Abe, Hisashi Uhara, Hirofumi Ohnishi et al.
1 links
The Journal of Dermatology
COVID-19 and healthcare impacts
article

Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan

Atsushi Miyawaki, Kazuhiro Abe, Hisashi Uhara, Hirofumi Ohnishi, Tomoyo Sato
article en

Abstract

During the COVID-19 pandemic, a decline in various infectious disease cases was observed. However, changes in dermatological infectious diseases, particularly cellulitis, and the potential impact of delayed consultations on severe cases have not been fully explored. To investigate changes in the number of cellulitis patients and severe cases during the COVID-19 pandemic. We employed a difference-in-differences (DID) design using a de-identified claims database from 242 acute-care hospitals across Japan to compare the pre-pandemic period (January 1, 2015, to December 31, 2019) with the pandemic period (January 1, 2020, to December 31, 2020). The national state of emergency, declared by the Japanese government in April 2020 in response to COVID-19, was treated as an exogenous shock. The study analyzed outpatient, inpatient, and total cases, sepsis and bacteremia complications, ambulance transport rates, length of hospital stay, and inpatient comorbidities. A total of 28 673 cellulitis cases were analyzed (24 256 from 2015 to 2019; 4417 in 2020). Severity indicators included hospitalization (8.2%), sepsis (4.1%), bacteremia (1.7%), and ambulance transport (17.0%). In the DID analysis, a significant decrease was observed in total cellulitis cases (incidence rate ratio [IRR]: 0.91; 95% confidence interval [CI]: 0.85-0.97), outpatient cases (IRR: 0.92; 95% CI: 0.86-0.98), and inpatient cases (IRR: 0.81; 95% CI: 0.66-0.99). No significant differences were found in sepsis (IRR: 0.53; 95% CI: 0.26-1.10), bacteremia (IRR: 0.73; 95% CI: 0.19-2.86), ambulance transport (IRR: 0.81; 95% CI: 0.50-1.29), or length of hospital stay (IRR: 0.83; 95% CI: 0.66-1.03). During the pandemic, the number of cellulitis cases treated in Japanese acute-care hospitals decreased without a significant rise in severe cases, suggesting the possibility that avoidance of medical consultations may not have worsened outcomes. Pandemic-related behavioral changes may have contributed to the reduced incidence.

The Journal of DermatologyVol. 52(10)
Sapporo Medical University (JP), Sapporo University (JP), University of Tokyo Health Sciences (JP), Department of Health (IE), The University of Tokyo (JP)
Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 75%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.